Literature DB >> 18645902

Sequence of the haemagglutinin-neuraminidase gene of the Newcastle disease virus oral vaccine strain V4(UPM).

K Yusoff1, W S Tan, C H Lau, B K Ng, A L Ibrahim.   

Abstract

The nucleotide sequence of the haemagglutinin-neuraminidase (HN) glycoprotein gene of Newcastle disease virus (NDV) variant strain V4(UPM) was determined by direct genomic RNA sequencing and confirmed by cycle sequencing. The gene comprises 1996 nucleotides encoding a 615 amino acid protein of size 67.4 kDa. The nucleotide and amino acid sequences of this strain were compared with those of the parent strain V4(QUE). There are 16 nucleotide substitutions on V4(UPM), eight of which are silent mutations and another eliminated a potential Asn-linked glycosylation site in V4(UPM). In addition, an Arg (403) residue was shown to be absent in the variant strain. This deletion is thought to be significant because of its location in a highly conserved region of the HN protein.

Entities:  

Year:  1996        PMID: 18645902     DOI: 10.1080/03079459608419185

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  12 in total

1.  Cloning and expression of the HN gene from the velogenic viscerotropic Newcastle disease virus strain AF2240 in Sf9 insect cells.

Authors:  H K Ong; A M Ali; A R Omar; K Yusoff
Journal:  Cytotechnology       Date:  2000-03       Impact factor: 2.058

2.  Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.

Authors:  Wei-Choong Ch'ng; Noraini Abd-Aziz; Meng-Hua Ong; Eric J Stanbridge; Norazizah Shafee
Journal:  Cell Oncol (Dordr)       Date:  2015-05-01       Impact factor: 6.730

3.  Site-specific glycosylation of the Newcastle disease virus haemagglutinin-neuraminidase.

Authors:  Cassandra L Pegg; Christine Hoogland; Jeffrey J Gorman
Journal:  Glycoconj J       Date:  2016-12-07       Impact factor: 2.916

4.  Cytolytic effects and apoptosis induction of Newcastle disease virus strain AF2240 on anaplastic astrocytoma brain tumor cell line.

Authors:  Rola Ali; Aied M Alabsi; Abdul Manaf Ali; Aini Ideris; Abdul Rahman Omar; Khatijah Yusoff; Riyadh Saif-Ali
Journal:  Neurochem Res       Date:  2011-06-14       Impact factor: 3.996

5.  Molecular Characterization of Thermostable Newcastle disease virus Isolated from Pigeon.

Authors:  A Uthrakumar; K Vijayarani; K Kumanan; V Thiagarajan
Journal:  Indian J Virol       Date:  2013-01-29

6.  Complete genome sequence and molecular characterization of thermostable Newcastle disease virus strain TS09-C.

Authors:  Guoyuan Wen; Yu Shang; Jing Guo; Chen Chen; Huabin Shao; Qingping Luo; Jun Yang; Hongling Wang; Guofu Cheng
Journal:  Virus Genes       Date:  2013-01-08       Impact factor: 2.332

7.  The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling.

Authors:  Wei-Choong Ch'ng; Eric J Stanbridge; Khatijah Yusoff; Norazizah Shafee
Journal:  J Interferon Cytokine Res       Date:  2013-03-18       Impact factor: 2.607

8.  Effects of newcastle disease virus strains AF2240 and V4-UPM on cytolysis and apoptosis of leukemia cell lines.

Authors:  Aied M Alabsi; Siti Aishah Abu Bakar; Rola Ali; Abdul Rahman Omar; Mohd Hair Bejo; Aini Ideris; Abdul Manaf Ali
Journal:  Int J Mol Sci       Date:  2011-11-30       Impact factor: 5.923

9.  Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240.

Authors:  Mohamed Ghrici; Mohamed El Zowalaty; Abdul Rahman Omar; Aini Ideris
Journal:  Oncol Rep       Date:  2013-06-27       Impact factor: 3.906

10.  Establishment of an in vitro system representing the chicken gut-associated lymphoid tissue.

Authors:  Noorjahan Banu Alitheen; Susan Jane McClure; Swee Keong Yeap; Ye Wen Kristeen-Teo; Sheau Wei Tan; Peter McCullagh
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.